Therapeutically Trig... 申请号：US16096120 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention provides therapeutic compositions that present an artificial repertoire of mammalian pattern recognition receptor (PRR) agonists, so that the pattern of PRR agonists recapitulates a dis...
Therapeutic protein-... 申请号：AU2017394978 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention belongs to the technical field of nanomedicine, and relates to a method for preparing a therapeutic protein-loaded nanoparticle, as well as a therapeutic protein-loaded nanopar...
Therapeutic compound... 申请号：AU2017347549 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention provides a compound of formula I : or a pharmaceutically acceptable salt thereof, wherein the variables X, Y
Therapeutic compound... 申请号：CL2019001041 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
or a pharmaceutically acceptable salt thereof, wherein the variables X, Y1-Y5, R1, R2, R3, R4, and Het have the meaning as described herein, and compositions containing such compounds and meth...
Therapeutic compound... 申请号：JP2018539318 专利类型：发明申请 公开（公告）日：2017-01-30
状态：寻求转化 转让价格：面议
The present invention relates to compounds that are antagonists of the orexin-1 receptor. The compounds have the structural formula (I) defined herein. The present invention also relates to processes ...
Therapeutic composit... 申请号：US15346335 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtr...
Therapeutic composit... 申请号：US15346335 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtr...
Therapeutic apoptoti... 申请号：JP2015546150 专利类型：发明授权 公开（公告）日：2013-12-05
状态：寻求转化 转让价格：面议
The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and use...
Their use as an inhi... 申请号：JP2017505452 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
Substituted bicyclic dihydropyrimidinones of formula 1 which are inhibitors of neutrophil elastase activity and useful as medicaments for the treatment of, inter alia, COPD. Exemplary is
Their use as an inhi... 申请号：JP2017505234 专利类型：发明授权 公开（公告）日：2015-07-30
状态：寻求转化 转让价格：面议
Substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity. An exemplary compound is
